SCHEMBL30134079

SCHEMBL30134079

COC(=O)c1nn(C2CCCCO2)cc1NC(C)=O

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.38
ABL1 P00519 1/20 0.36
ALDH1A1 P00352 6/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 1/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CD274 Q9NZQ7 1/20 0.33
OPRK1 P41145 1/20 0.32
ATR Q13535 2/20 0.32
POLQ O75417 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30134275 0.89 ALDH1A1 (0.40) ABL1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL30899981 0.88 CNR2 (0.36) CNR2ABL1ALDH1A1MEN1KMT2A
SCHEMBL5821921 0.86 CNR2 (0.35) CNR2ABL1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4287690 0.85 HTT (0.46) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL4279778 0.85 POLB (0.44) ALDH1A1SMN1; SMN2TSHRNPC1RAB9A
SCHEMBL8273357 0.82 CCNA2 (0.39) ABL1MEN1KMT2ANPC1RAB9A
SCHEMBL3583397 0.82 POLB (0.42) ABL1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL4285703 0.82 MAPT (0.43) SMN1; SMN2NPC1RAB9A
SCHEMBL25187420 0.82 ABL1 (0.38) ABL1ALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL3581037 0.82 CFTR (0.36) ABL1ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658656-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES Beone Medicines I GmbH (CH) 2025-12-10 EP disclosed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 US disclosed
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 CN disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
WO-2024160276-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEIGENE, LTD. (KY) 2024-08-08 WO disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN disclosed
WO-2023011456-A1 PYRAZOLOPYRIDINONE COMPOUNDS BEIGENE, LTD. (KY) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300951-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK CNR2 2830/4885ABL1 687/4885ALDH1A1 1296/4885
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK CNR2 1631/4885ABL1 810/4885ALDH1A1 4075/4885
US-20240270751-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK CNR2 2830/4885ABL1 687/4885ALDH1A1 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.